Advanced Lymphosarcoma: Intensive Cyclical Combination Chemotherapy with Cyclophosphamide, Vincristine, and Prednisone (Q70465384)
scientific article published on 01 February 1972
Language:
Current Data About Advanced Lymphosarcoma: Intensive Cyclical Combination Chemotherapy with Cyclophosphamide, Vincristine, and Prednisone
(P31) (Q13442814)
(P248)
(P698) 5066691
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5066691%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, October 11, 2019

(P304) 227-234
(P248)
(P698) 5066691
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5066691%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, October 11, 2019

(P407) (Q1860)

(P433) 2
(P248)
(P698) 5066691
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5066691%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, October 11, 2019

(P478) 76
(P248)
(P698) 5066691
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5066691%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, October 11, 2019

(P577) Tuesday, February 1, 1972
(P248)
(P698) 5066691
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5066691%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, October 11, 2019

(P921) (Q974135)
(P887)

(Q11180)
(P248)
(P356) 10.7326/0003-4819-76-2-227
(P854) https://api.crossref.org/works/10.7326/0003-4819-76-2-227
(P813) Monday, April 3, 2023

(P1433) (Q564416)
(P248)
(P698) 5066691
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5066691%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, October 11, 2019

(P1476) "Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone" (language: en)
(P248)
(P698) 5066691
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5066691%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, October 11, 2019

(P2093) C. M. Bagley
(P1545) 1
(P248)
(P698) 5066691
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5066691
(P813) Monday, April 3, 2023

V. T. Devita
(P1545) 2
(P248)
(P698) 5066691
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5066691
(P813) Monday, April 3, 2023

C. W. Berard
(P1545) 3
(P248)
(P698) 5066691
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5066691
(P813) Monday, April 3, 2023

G. P. Canellos
(P1545) 4
(P248)
(P698) 5066691
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5066691
(P813) Monday, April 3, 2023

other details
description scientific article published on 01 February 1972

External Links
(P356) 10.7326/0003-4819-76-2-227
(P698) 5066691